Michael Mason, VP, Finance and Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 3,750 shares at $62.12 ($232K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Scheduled sale ($232k) by VP, Finance and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.55 | 1,905 | $117K | 50.6% |
| 2 | $62.12 | 1,845 | $115K | 49.4% |
| Total | $61.83 avg | 3,750 | $232K | 100% |
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |